Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology
Description: New insights from genome sequencing and technical advances in genome editing, chemical biology, and cellular engineering are providing unprecedented opportunities for advances in cancer treatment. The emerging complexity of cancer biology and increasing sophistication of experimental therapeutics demand a level of understanding and training in research methodology beyond the scope of conventional fellowship programs. To address these challenges, the goal of the Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology (DF/HCC K12) is to recruit and select a highly qualified group of Scholars to complete a rigorous two to three year program of didactic instruction and mentored research that will prepare them for independent careers in clinical oncology research.
Funder: National Cancer Institute
Funding type: career_development
Funder scheme: K12
Start date: 2000-07-01
End date: 2028-03-31
Investigator: BRUCE ALLAN CHABNER
Institution: MASSACHUSETTS GENERAL HOSPITAL
Funded outputs count: 252
Funder award ID: K12CA087723
OpenAlex ID: G9000897310